Dr. Caporale’s work in the pharmaceutical, and biotechnology industries as well as academia, has given her time to absorb the needs and perspective of most of ILSE’s planned stakeholders. During over a decade at Merck Research Laboratories, she rose to be responsible for identifying and evaluating technologies and breakthrough therapies in a wide range of therapeutic areas and for structuring and negotiating scientific milestones in collaborations with other pharmaceutical companies, biotechnology companies, and a research institute. She served in senior strategic leadership roles in seed-stage biotechnology companies, successfully negotiating deals with pharmaceutical companies and obtaining STTR funding. Dr. Caporale was a retained consultant for MDS Capital Corp and served on SABs and BODs. In academia, she has taught undergraduates (both majors and non-majors), graduate, dental, and medical students, and served as a mentor for students and postdocs. She served on the faculty of Georgetown University Medical School, St. John’s University (adjunct) and also taught at Columbia University where she served as Associate Director of the Genome Center; she served a full term on the NIH Physiological Chemistry Study Section and as an ad hoc member of other grant review panels. In addition to her scientific publications, Dr. Caporale has written a book for nonscientists, has been interviewed by CNN and NPR and organized and led several international interdisciplinary conferences. She has a Ph.D. in Molecular Biology from the University of California at Berkeley, a B.S. with Honors in Chemistry from Brooklyn College of CUNY, and postdoctoral training at MSKCC, NYU and Rockefeller University.